Literature DB >> 17322812

Oral pathology in a group of Mexican patients with genetic diseases.

Luis A Montoya Pérez1, María de la Luz Arenas Sordo, Edgar Hernández Zamora, Beatriz C Aldape Barrios.   

Abstract

UNLABELLED: Without considering infectious and traumatic diseases, the great majority of oral cavity diseases have a genetic base, in some cases identifiable, in others not. For the stomatologists it is of great importance to know the clinical characteristics and type of alteration that go with genetic etiology syndromes to be able to offer patients an adequate multidisciplinary treatment.
OBJECTIVE: Intentional search and description of oral pathology in patients with diverse genetic diseases. STUDY
DESIGN: An observational and descriptive 4 month study of 62 patients from the Genetics Department of the National Institute of Rehabilitation, was done. Taken into consideration, aside from oral manifestations and genetic disease, were age, sex, consanguinity and inbreeding. The majority of patients who have genetic pathology do not have curative treatment, but they can receive other treatments to improve their quality of life, among these are dental treatments.
RESULTS: The more common diseases we found were hereditary peripheral neuropathies, skeletal dysplasias, limb malformation and muscular dystrophies. Diverse features were described, registered and grouped according to their location.
CONCLUSIONS: Presently it is important to look for the genetic etiology of all diseases to seek specific treatments and prevent them. This will change the practice of medicine and dentistry.

Entities:  

Mesh:

Year:  2007        PMID: 17322812

Source DB:  PubMed          Journal:  Med Oral Patol Oral Cir Bucal        ISSN: 1698-4447


  1 in total

1.  Goldenhar syndrome: clinical features with orofacial emphasis.

Authors:  Hercílio Martelli; Roseli Teixeira de Miranda; Cassandro Moreira Fernandes; Paulo Rogério Ferreti Bonan; Lívia Máris Ribeiro Paranaíba; Edgard Graner; Ricardo D Coletta
Journal:  J Appl Oral Sci       Date:  2010-12       Impact factor: 2.698

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.